Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 Supplementation in Prostate Cancer Active Surveillance
NCT04621500Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jun 2019
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vitamin d in prostate cancer (PCa), sponsored by Medical University of South Carolina. Primary endpoint: Percentage of Participants With Change in Transcriptional Profiles After Vitamin D Supplementation at 1 year. Started Jun 2019; status: completed.
02
Drugs
vitamin d
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04621500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04621500.